Valuation: Orion Oyj

Market Cap 13.44B 14.97B 12.41B 11.25B 21.03B 1,422B 21.29B 149B 59.08B 745B 56.21B 55B 2,364B P/E 2026 *
23.2x
P/E 2027 * 19.4x
Enterprise Value 13.33B 14.85B 12.31B 11.16B 20.86B 1,411B 21.12B 148B 58.61B 740B 55.76B 54.56B 2,345B EV / Sales 2026 *
6.32x
EV / Sales 2027 * 5.44x
Free-Float
90.5%
Yield 2026 *
2.07%
Yield 2027 * 2.34%
1 day-0.10%
1 week+8.38%
Current month+15.72%
1 month+16.14%
3 months+20.83%
6 months+41.57%
Current year+51.18%
1 week 89
Extreme 89
97.7
1 month 75
Extreme 75
97.7
Current year 62.3
Extreme 62.3
97.7
1 year 56.3
Extreme 56.3
97.7
3 years 32.5
Extreme 32.5
97.7
5 years 32.5
Extreme 32.5
97.7
10 years 24.75
Extreme 24.75
97.7
Manager TitleAgeSince
Chief Executive Officer 59 2022-10-31
Director of Finance/CFO 50 2024-04-30
Chief Operating Officer 46 2021-12-31
Director TitleAgeSince
Director/Board Member 63 2017-03-21
Director/Board Member 65 2017-03-21
Director/Board Member 66 2020-05-05
Change 5-day change 1-year change 3-year change Capi.($)
-0.10%+8.38% - - 15.11B
+0.22%-0.14%+55.12%+128.82% 1,140B
+0.91%+3.61%+41.21%+84.57% 641B
-0.12%-0.93%+25.59%+106.14% 507B
+0.63%+2.33%+49.21%+67.82% 383B
+0.86%-4.37%+61.16%+37.93% 347B
+1.02%+1.80%+24.84%+53.75% 293B
-0.25%+1.62%+2.20%+26.65% 266B
+0.75%+2.05%+53.85%+71.25% 240B
+0.25%+1.64%+32.05%+107.62% 197B
Average +0.42%+1.16%+38.36%+76.06% 445.98B
Weighted average by Cap. +0.44%+0.96%+42.20%+88.48%

Financials

2026 *2027 *
Net sales 2.11B 2.35B 1.95B 1.77B 3.3B 223B 3.34B 23.35B 9.27B 117B 8.82B 8.63B 371B 2.4B 2.67B 2.22B 2.01B 3.75B 254B 3.8B 26.56B 10.55B 133B 10.03B 9.82B 422B
Net income 580M 647M 536M 486M 908M 61.41B 919M 6.42B 2.55B 32.19B 2.43B 2.38B 102B 695M 774M 642M 582M 1.09B 73.53B 1.1B 7.69B 3.05B 38.54B 2.91B 2.84B 122B
Net Debt -107M -119M -98.93M -89.71M -168M -11.34B -170M -1.19B -471M -5.94B -448M -439M -18.85B -381M -425M -352M -319M -596M -40.32B -604M -4.22B -1.68B -21.14B -1.59B -1.56B -67.03B
Projected Income Statement - Annual - Orion Oyj
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,000
Date Price Change Volume
26-10-27 €95.70 -0.10% 23,695
26-10-26 €95.80 +4.36% 22,989
26-10-23 €91.80 +0.33% 10,721
26-10-22 €91.50 +2.81% 18,608
26-10-21 €89.00 +0.79% 8,811
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Orion Oyj
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
95.75EUR
Average target price
85.33EUR
Spread / Average Target
-10.88%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Orion Oyj